Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Operating Expenses 2010-2024 | AMRX

AMNEAL PHARMACEUTICALS, INC operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
AMNEAL PHARMACEUTICALS, INC Annual Operating Expenses
(Millions of US $)
2023 $2,189
2022 $2,307
2021 $1,941
2020 $1,901
2019 $1,875
2018 $1,683
2017 $789
2016 $733
2015 $791
2014 $507
2013 $518
2012 $499
2011 $413
2010 $486
2009 $288
AMNEAL PHARMACEUTICALS, INC Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $614
2024-06-30 $606
2024-03-31 $670
2023-12-31 $603
2023-09-30 $544
2023-06-30 $519
2023-03-31 $523
2022-12-31 $574
2022-09-30 $501
2022-06-30 $758
2022-03-31 $474
2021-12-31 $526
2021-09-30 $500
2021-06-30 $468
2021-03-31 $447
2020-12-31 $490
2020-09-30 $517
2020-06-30 $454
2020-03-31 $441
2019-12-31 $420
2019-09-30 $491
2019-06-30 $424
2019-03-31 $540
2018-12-31 $474
2018-09-30 $402
2018-06-30 $595
2018-03-31 $212
2017-12-31 $161
2017-09-30 $176
2017-06-30 $215
2017-03-31 $236
2016-12-31 $-123
2016-09-30 $501
2016-06-30 $168
2016-03-31 $188
2015-12-31 $251
2015-09-30 $194
2015-06-30 $196
2015-03-31 $150
2014-12-31 $130
2014-09-30 $132
2014-06-30 $134
2014-03-31 $110
2013-12-31 $117
2013-09-30 $133
2013-06-30 $124
2013-03-31 $144
2012-12-31 $136
2012-09-30 $116
2012-06-30 $136
2012-03-31 $110
2011-12-31 $123
2011-09-30 $94
2011-06-30 $108
2011-03-31 $88
2010-12-31 $89
2010-09-30 $181
2010-06-30 $104
2010-03-31 $112
2009-12-31 $124
2009-09-30 $55
2009-06-30 $54
2009-03-31 $55
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.432B $2.394B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.873B 31.52
Zoetis (ZTS) United States $70.142B 26.46
Daiichi Sankyo, - (DSNKY) $43.872B 26.73
Takeda Pharmaceutical (TAK) Japan $43.719B 9.68
Sandoz Group AG (SDZNY) Switzerland $20.592B 0.00
Merck (MKKGY) Germany $18.255B 16.35
Astellas Pharma (ALPMY) Japan $17.355B 12.30
United Therapeutics (UTHR) United States $17.000B 16.72
Summit Therapeutics (SMMT) United States $15.929B 0.00
Shionogi (SGIOY) Japan $12.267B 12.29
Neurocrine Biosciences (NBIX) United States $11.392B 34.73
Corcept Therapeutics (CORT) United States $7.704B 58.36
Madrigal Pharmaceuticals (MDGL) United States $7.495B 0.00
Orion OYJ (ORINY) Finland $7.424B 20.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.166B 39.92
Grifols, S.A (GRFS) Spain $5.074B 0.00
Ionis Pharmaceuticals (IONS) United States $5.023B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.247B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.394B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.098B 0.00
Soleno Therapeutics (SLNO) United States $2.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.766B 0.00
Evotec AG (EVO) Germany $1.566B 0.00
Ardelyx (ARDX) United States $1.506B 0.00
Indivior (INDV) United States $1.504B 6.13
Dyne Therapeutics (DYN) United States $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
ARS Pharmaceuticals (SPRY) United States $1.166B 0.00
Ocular Therapeutix (OCUL) United States $1.160B 0.00
Xencor (XNCR) United States $1.134B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 0.00
Harrow (HROW) United States $1.078B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Collegium Pharmaceutical (COLL) United States $0.965B 5.27
Bioventus (BVS) United States $0.838B 26.46
Avadel Pharmaceuticals (AVDL) Ireland $0.810B 0.00
Cronos Group (CRON) Canada $0.750B 0.00
Relay Therapeutics (RLAY) United States $0.696B 0.00
Verve Therapeutics (VERV) United States $0.683B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.02
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.529B 0.00
OmniAb (OABI) United States $0.518B 0.00
Elite Pharmaceuticals (ELTP) United States $0.509B 0.00
Altimmune (ALT) United States $0.482B 0.00
Savara (SVRA) United States $0.481B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.479B 0.00
ProKidney (PROK) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.444B 0.00
Akebia Therapeutics (AKBA) United States $0.432B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Zevra Therapeutics (ZVRA) United States $0.413B 0.00
Aldeyra Therapeutics (ALDX) United States $0.404B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.363B 147.29
Tourmaline Bio (TRML) United States $0.323B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
CytoDyn (CYDY) United States $0.292B 0.00
Korro Bio (KRRO) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.276B 0.00
Avita Medical (RCEL) United States $0.268B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.71
Heron Therapeutics (HRTX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
4D Molecular Therapeutics (FDMT) United States $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
Larimar Therapeutics (LRMR) United States $0.211B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Nektar Therapeutics (NKTR) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.181B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.177B 0.00
Nanobiotix S.A (NBTX) France $0.170B 0.00
Acrivon Therapeutics (ACRV) United States $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Inotiv (NOTV) United States $0.132B 0.00
ElectroCore (ECOR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.096B 0.00
Galectin Therapeutics (GALT) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Protara Therapeutics (TARA) United States $0.082B 0.00
Pyxis Oncology (PYXS) United States $0.080B 0.00
Nutriband (NTRB) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.08
Karyopharm Therapeutics (KPTI) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
AleAnna (ANNA) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.057B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.056B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
BioVie (BIVI) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mangoceuticals (MGRX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00